MOLNMOLECULAR PARTNERS AG

Nasdaq molecularpartners.com


$ 6.02 $ -0.81 (-11.81 %)    

Monday, 05-Aug-2024 15:58:02 EDT
QQQ $ 446.16 $ 8.36 (1.91 %)
DIA $ 392.28 $ 5.47 (1.41 %)
SPY $ 528.29 $ 8.77 (1.69 %)
TLT $ 96.90 $ -1.14 (-1.16 %)
GLD $ 221.18 $ -0.27 (-0.12 %)
$ 6.01
$ 6.00 x 200
-- x --
-- - --
$ 3.32 - $ 12.70
5,228
na
218.49M
$ 1.04
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

Core News & Articles
Market-Moving News for June 14th
06/14/2024 12:34:25

ADBE: 16% | Adobe shares are trading higher following better-than-expected Q2 earnings and strong guidance. BPTH: 46% | Bio-Pa...

 molecular-partners-reveals-preclinical-data-for-first-switch-darpin-candidate-mp0621-at-eha-2024

Proof-of-concept of Switch-DARPin platform established in vivo, enabling the use of logic-gated and reversible immune activat...

Core News & Articles
Market-Moving News for June 11th
06/11/2024 12:29:09

MOLN: 11% | Molecular Partners shares are trading higher after the company announced the debut of their lead Raido-DARPin thera...

 reported-saturday-molecular-partners-presented-data-from-completed-phase-1-trial-of-mp0317-monotherapy-in-advanced-solid-tumors-at-asco-2024

Mechanism of action supported by observed MP0317 localization and immune cell activation in the tumor microenvironment Favor...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION